FiscalNote Announces Major Expansion Into Political Prediction Markets
Unveils Political Predictions Preview Site Enters Into Strategic Partnership Memorandum of Understanding (MOU) with Prediction Market Technology Company 365Prediction... Read more.
AXA and Planet Partner to Revolutionize Disaster Management and Prevention
BERLIN–(BUSINESS WIRE)–Planet Labs GmbH, a leading provider of daily data and insights about change on Earth, today announced a strategic partnership... Read more.
Palantir Receives DISA Authorization for PFCS Forward, Extending IL5 and IL6 Accreditation to On-Premises and Edge Deployments
Authorization Enables “Authorize Once, Use Many” Model Across Any Hardware DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (NASDAQ: PLTR)... Read more.
Sustainability Emerges as a Core Cost Strategy for Transportation Leaders Amid Market Volatility, New Breakthrough Research Finds
As tariff uncertainty and inflation persist, new data reveals shippers are embedding emissions reduction into day-to-day transportation decisions GREEN BAY, Wis.–(BUSINESS... Read more.
Trinity Industries, Inc. Announces Fourth Quarter and Full Year 2025 Results
Reports full year earnings from continuing operations of $3.14 per diluted share Generates full year operating cash flow of $367 million Net gains on lease portfolio... Read more.
NuScale Power to Collaborate with Oak Ridge National Laboratory to Explore Artificial Intelligence-Guided Nuclear Fuel Management
The collaboration will utilize an artificial intelligence-enabled nuclear design framework to strategically explore and optimize fuel management across multiple... Read more.
Exelon Reports Fourth Quarter and Full Year 2025 Results and Initiates 2026 Financial Outlook
Earnings Release Highlights Executed Adjusted (non-GAAP) operating earnings per share above expectations, with GAAP net income of $0.58 per share and Adjusted (non-GAAP)... Read more.
Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium
Late-breaking KEYNOTE-B15 data show KEYTRUDA® (pembrolizumab) plus Padcev® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival... Read more.
Granite Reports Fourth Quarter and Fiscal Year 2025 Results
Committed and Awarded Projects (“CAP”) (1) increased 32% year-over-year to $7.0 billion, a new record Q4 revenue increased 19% year-over-year to $1.2 billion,... Read more.
Iron Mountain Reports Fourth Quarter and Full Year 2025 Results
Delivers record quarterly and full year results across all key performance metrics Achieves quarterly and full year revenue of $1.8 billion and $6.9 billion, reflecting... Read more.